[PubMed] Abhijit Basu A, Dvorina N, Baldwin W, Mazumder B
Peptide Therapeutics: Current Status and Future Directions. Drug Discovery Today , 20(1), 122-128, 2015
The 4mg dose represents the first truly therapeutic level
The 22.5% average weight loss, with some patients achieving 25%+ reductions, offers the best chance of reaching a healthy weight range
Preclinical studies of the individual components report: BPC-157: modulation of angiogenic markers, fibroblast activity and gastro-intestinal lining integrity in various in-vitro and in-vivo models
Among those team members were co-first authors Shanshan Liu, a postdoc in the lab who has long researched mitochondrial metabolism, and Mark Gad, a Ph.D student jointly supervised by Birsoy and Richard Hite, of Memorial Sloan Kettering Cancer Center